scientific program - World Allergy Organization
scientific program - World Allergy Organization
scientific program - World Allergy Organization
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
WAO Congress–XVIII ICACI Final Program<br />
WEDNESDAY, 10 SEPTEMBER- continued<br />
POSTER SESSIONS<br />
P-15-29 Modulation of allergic response by chemically modified<br />
allergen and immunomodulator Polyoxidonium<br />
Babakhin AA1 , Andreev SM1 , Petrukhina AO1 , Puchkova NI1 ,<br />
Khaitov RM1 , DuBuske LM2 , Petrov RV1 1National Research Center - Institute of Immunology, Moscow,<br />
Russian Federation, 2Immunology Research Institute of New<br />
England, Fitchburg, MA, USA<br />
P-15-30 Modulation of the IgE response to Alternaria after DNA<br />
vaccination with the major Alternaria allergens (rAlta1 and<br />
rAlta2) in a brown Norway rat model<br />
Montalbano MM1 , Sanchez H2 , Keyes EL2 , Rosenthal LA1 , Sorkness<br />
RL3 , Bush RK1 1University of Wisconsin Medical School, Madison, WI, USA,<br />
2William S Middleton VA Medical Center, Madison, WI, USA,<br />
3University of Wisconsin-Madison School of Pharmacy, Madison,<br />
WI, USA<br />
Rhinosinusitis<br />
P-16-1 The prospective and retrospective significance of surgical<br />
correction of obstructive changes in the nasopharynx had<br />
improved not only nocturnal snoring<br />
Ishaq IM1 1Al-Junaid Hospital, Nowshera, NWFP, Pakistan<br />
P-16-2 Diagnosis & management care in a limited resource of a<br />
primary care setting<br />
Jamal EJ1 1University Putra Malaysia, Kuala Lumpur, Selangor, Malaysia<br />
P-16-3 Efficacy and safety of mometasone furoate nasal spray for<br />
prophylactic treatment of intermittent moderate/severe<br />
allergic rhinitis<br />
Papadopoulos NG1 , Papadopoulos D2 , Kompoti E3 , Manoussakis<br />
E1 , Tassios I1 , Pitsios K3 , Baibas N4 , Kontou-Fili K3 , Saxoni-<br />
Papageorgiou P5 1<strong>Allergy</strong> Department, 2nd Pediatric Clinic, Univ. of Athens, Athens,<br />
Greece, 2 "424" General Army Hospital, Thessaloniki, Greece,<br />
3 4 Laikon General Hospital, Athens, Greece, Epidemiology Dept.,<br />
Univ. of Athens, Athens, Greece, 5<strong>Allergy</strong> Department, Univ. of<br />
Athens, Athens, Greece<br />
P-16-4 The content of fatty acids in erythrocyte membranes in<br />
pollinosis children in long remission period<br />
Terechtchenko S1 , Babushkin V2 , Terechtchenko V2 1State Medical Research Institute for Northern Problems,<br />
Krasnoyarsk, Russian Federation, 2State Krasnoyarsk Medical<br />
Academy, Krasnoyarsk, Russian Federation<br />
P-16-5 A virtual model for human nasal mucosa and the influence of<br />
individual specific allergic reactions<br />
Strauss GS1 , Winkler DW2 , Nowatius EN3 , Mueller HM1 1Dept. of Otorhinolaryngology/University of Leipzig, Leipzig,<br />
Germany, 2Dept. of Neurosurgery/University of Leipzig, Leipzig,<br />
Germany, 3Zwonull Inc., Leipzig, Germany<br />
P-16-6 Increased number of CD34+ cells in nasal mucosa of allergic<br />
rhinitis patients: inhibition by a local glucocorticoid<br />
Sergejeva S1 , Lotvall Jtvall J> 1 , Pullerits T1 1Lung Pharmacology Group, Göteborg University, Gothenburg,<br />
Sweden<br />
P-16-7 Allergic rhinitis in Delhi: a comparative profile of “sneezers<br />
and runners” and “blockers”<br />
Khanna P1 , Shah A1 1V P Chest Institute, University of Delhi, Delhi, India<br />
P-16-8 Early revealings of allergic rhinitis<br />
Chopyak V 1 , Lishchuk K 1<br />
1 Lviv State Medical University, Lviv, Ukraine<br />
85<br />
P-16-9 Seasonal allergic rhinitis (SAR) - circadian variation - timing of<br />
desloratadine (DL) dosing<br />
Haye R1 , Hoye Kye K> 2 , Berg O3 , Frones Snes S> 4 , Ädegård T4 1 2 Rikshospitalet, Oslo, Norway, Helsetorget Legesenter, Elverum,<br />
Norway, 3Betania, Stockholm, Sweden, 4Schering-Plough, Eiksmarka, Norway<br />
P-16-10 Prevalence of allergic rhinitis among asthmatics in eastern<br />
India<br />
Jodhani K1 , Barman NN2 1 2 Asthma <strong>Allergy</strong> Center, Guwahati, Assam, India, Guwahati Medical<br />
College, Guwahati, Assam, India<br />
P-16-11 Allergic rhinitis: diagnosis and misdiagnosis<br />
Krupski MH1 , Tshifularo MI1 , Vorster W1 1Medunsa - Medical University of South Africa, Pretoria, Gauteng,<br />
South Africa<br />
P-16-12 Genetic variants of ADAM33 in Japanese cedar pollinosis<br />
Cheng L1 , Enomoto T2 , Shimizu M3 , Hirota T3 , Tamari M3 ,<br />
Shirakawa T1 1Department of Health Promotion and Human Behavior, Kyoto<br />
University, Kyoto, Japan, 2Department of ORL, Japanese Red Cross<br />
Society Wakayama Medical Center, Wakayama, Japan, 3Laboratory for Genetics of Allergic Disease, RIKEN SNP Research Center,<br />
Yokohama, Japan<br />
P-16-13 Intracellular cytokines in T helper cells in intermittent allergic<br />
rhinitis<br />
Glück J1 , Mazur B2 , Rogala B1 1Chair & Dept. of Internal Diseases, Allergology and Cli. Immunol,<br />
Zabrze, Poland, 2Dept. of Pathophysiology, Zabrze, Poland<br />
P-16-14 Evaluation of the safety and efficacy of oral fexofenadine in<br />
pediatric subjects with seasonal allergic rhinitis: pooled analysis<br />
of three studies<br />
Meltzer E1 , Scheinmann P2 , Rosado Pinto J3 , Bachert C4 , Hedlin<br />
G5 , Wahn U6 , Finn A7 , Ruuth E8 1<strong>Allergy</strong> and Asthma Medical Group and Research Center, San<br />
Diego, California, USA, 2Groupe Hospitalier Necker-Enfants<br />
Malades, Paris, France, 3Dona Estefania Hospital, Lisbon, Portugal,<br />
4 5 Ghent University, Ghent, Belgium, Karolinska Institutet,<br />
Stockholm, Sweden, 6University Children’s Hospital, Berlin,<br />
Germany, 7National <strong>Allergy</strong>, Asthma and Urticaria Centers,<br />
Charleston, SC, USA, 8Aventis Pharma, Romainville, France<br />
P-16-15 Fexofenadine effectively relieves seasonal allergic rhinitis in<br />
children from the South American Cone<br />
Baena-Cagnani C1 , Neffen H2 , Maspero J3 , Lisanti M4 , Portes R5 ,<br />
Hardy P6 , Ruuth E6 1 2 Hospital Infantil Municipal, Cordoba, Argentina, Centro de Alergia<br />
e Inmunologia, Sante Fe, Argentina, 3Hospital Ricardo Gutierrez,<br />
Capital Federal, Argentina, 4Instituto de Alergia e Immunologia,<br />
Mendoza, Argentina, 5Centro de Asma, Alergia y Immunologia<br />
Quilmes, Provincia de Buenos Aires, Argentina, 6Aventis Pharma,<br />
Paris, France<br />
P-16-16 Fexofenadine effectively relieves seasonal allergic rhinitis in<br />
children sensitized to a wide range of pollen categories<br />
Baena-Cagnani C 1 , Bernstein D 2 , Emeryck A 3 , Lisanti M 4 , Potter<br />
P 5 , Finn A 6 , Hardy P 7 , Ruuth E 7<br />
1 Hospital Infantil Municipal, Cordoba, Argentina, 2 Bernstein<br />
Clinical Research Center, Cincinnati, Ohio, USA, 3 Klinika<br />
Pulmonogii - CSK AM, Lublin, Poland, 4 Instituto de Alergia e<br />
Immunologia, Mendoza, Argentina, 5 University of Capetown,<br />
Mowbray, South Africa, 6 National <strong>Allergy</strong>, Asthma and Urticaria<br />
Centers, Charleston, South Carolina, USA, 7 Aventis Pharma, Paris,<br />
France<br />
WEDNESDAY